- Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin‐activatable fibrinolysis inhibitor activation and activated thrombin‐activatable fibrinolysis inhibitor activity(2016)
Authors: X. Zhou, S.D. Weeks, Paul Ameloot, S.V. Strelkov, P.J. Declerck
Pages: 1629 - 1638
- Production, purification and crystallization of a trans-sialidase from Trypanosoma vivax(2015)
Authors: Carole LF Haynes, Paul Ameloot, Hans Remaut, Yan G-J Sterckx, Stefan Magez
Pages: 577 - 585
- Structure of Ostertagia ostertagi ASP-1: insights into disulfide-mediated cyclization and dimerization(2013)
Authors: Jimmy Borloo, Peter Geldhof, Iris Peelaers, Frederik Van Meulder, Paul Ameloot, Edwin Claerebout, Sergei V Strelkov, Stephen D Weeks
Pages: 493 - 503
- X-ray structure of Ostertagia ostertagi ASP-1 provides detailed insights in dimerization mechanism and protein cyclization(2012)
Authors: Jimmy Borloo, Peter Geldhof, Iris Peelaers, Frederik Van Meulder, Paul Ameloot, Edwin Claerebout, Sergei Strelkov, Stephen D Weeks
Number of pages: 1
- Vaccine testing of recombinant versions of the protective activation-associated secreted proteins from the bovine abomasal parasite Ostertagia ostertagi(2011)
Authors: Peter Geldhof, Paul Ameloot, J Poot, Edwin Claerebout
Number of pages: 1
- The HAC1 gene from Pichia pastoris: characterization and effect of its overexpression on the production of secreted, surface displayed and membrane proteins(2010)
Authors: Mouna Guerfal, Stefan Ryckaert, Pieter Jacobs, Paul Ameloot, Kathleen Van Craenenbroeck
- Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease
Authors: Iván Alejandro Bontempi, Miguel Hernán Vicco, Gabriel Cabrera, Silvina Raquel Villar, Florencia Belén González, Eduardo Angel Roggero, Paul Ameloot, Ana Rosa Pérez, Iván Sergio Marcipar
Pages: 1274 - 1283